Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

There was a highly significant difference among the three study groups for the mortality outcome (p<0.001, Figure 1B ), again reflecting a poorer outcome among participants in the “TB” group.

also in 132,142 other papers

The low number of AIDS-defining diseases in our groups may have resulted in lower power to detect differences among the groups and may explain the fact that our results for the TB group did not reach statistical significance in the multivariate analysis for the composite primary outcome.

also in 111,027 other papers